OA10845A - Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments - Google Patents

Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments Download PDF

Info

Publication number
OA10845A
OA10845A OA9800150A OA9800150A OA10845A OA 10845 A OA10845 A OA 10845A OA 9800150 A OA9800150 A OA 9800150A OA 9800150 A OA9800150 A OA 9800150A OA 10845 A OA10845 A OA 10845A
Authority
OA
OAPI
Prior art keywords
formula
radical
compounds
methyl
dideoxy
Prior art date
Application number
OA9800150A
Other languages
English (en)
French (fr)
Inventor
Constantin Agouridas
Jean-Francois Chantot
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of OA10845A publication Critical patent/OA10845A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
OA9800150A 1996-02-28 1998-08-28 Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments OA10845A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
OA10845A true OA10845A (fr) 2003-02-05

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800150A OA10845A (fr) 1996-02-28 1998-08-28 Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments

Country Status (31)

Country Link
US (1) US6096714A (de)
EP (1) EP0885234B1 (de)
JP (1) JP4102440B2 (de)
KR (1) KR100486053B1 (de)
CN (1) CN1168734C (de)
AP (1) AP952A (de)
AR (1) AR005999A1 (de)
AT (1) ATE217633T1 (de)
AU (1) AU716204B2 (de)
BG (1) BG63207B1 (de)
BR (1) BR9707709B1 (de)
CZ (1) CZ293893B6 (de)
DE (1) DE69712610T2 (de)
DK (1) DK0885234T3 (de)
EA (1) EA001376B1 (de)
EE (1) EE9800265A (de)
ES (1) ES2176698T3 (de)
FR (1) FR2745290B1 (de)
HU (1) HU227567B1 (de)
IL (1) IL125622A (de)
NO (1) NO983955L (de)
NZ (1) NZ331600A (de)
OA (1) OA10845A (de)
PL (1) PL191736B1 (de)
PT (1) PT885234E (de)
SK (1) SK118498A3 (de)
TR (1) TR199801713T2 (de)
UA (1) UA58504C2 (de)
WO (1) WO1997031929A1 (de)
YU (1) YU37098A (de)
ZA (1) ZA971659B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004514643A (ja) * 1997-10-29 2004-05-20 大正製薬株式会社 エリスロマイシンa誘導体
AU9649598A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
WO2000044761A2 (en) 1999-01-27 2000-08-03 Pfizer Products Inc. Ketolide antibiotics
CZ20013733A3 (cs) * 1999-05-24 2002-11-13 Pfizer Products Inc. Deriváty 13-methylerythromycinu
AU6183700A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010880A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (de) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A-Derivate
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP2772254A3 (de) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Neuartige antibakterielle Mittel
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CN101917850B (zh) * 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ,インコーポレイテッド マラリア、結核、及びmac病の治療方法
CN108570083A (zh) 2010-03-22 2018-09-25 森普拉制药公司 大环内脂的结晶形式及其用途
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
AU2013239696C1 (en) 2012-03-27 2018-11-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (de) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von atemwegserkrankungen und formulierungen dafür
EP2968384A4 (de) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Konvergente verfahren zur herstellung antibakterieller makrolidmittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK0885234T3 (da) 2002-08-26
PL191736B1 (pl) 2006-06-30
NO983955D0 (no) 1998-08-27
WO1997031929A1 (fr) 1997-09-04
EA001376B1 (ru) 2001-02-26
KR19990087324A (ko) 1999-12-27
ATE217633T1 (de) 2002-06-15
AP9801318A0 (en) 1998-09-30
HUP9902576A1 (hu) 1999-12-28
CZ293893B6 (cs) 2004-08-18
EA199800768A1 (ru) 1999-02-25
SK118498A3 (en) 1999-07-12
AP952A (en) 2001-03-29
TR199801713T2 (xx) 1998-12-21
US6096714A (en) 2000-08-01
ZA971659B (en) 1998-02-26
NO983955L (no) 1998-08-27
EP0885234A1 (de) 1998-12-23
BR9707709A (pt) 1999-04-06
AU716204B2 (en) 2000-02-24
IL125622A (en) 2003-10-31
CN1212700A (zh) 1999-03-31
FR2745290B1 (fr) 1998-04-03
DE69712610T2 (de) 2002-11-28
AU1929897A (en) 1997-09-16
YU37098A (sh) 1999-07-28
NZ331600A (en) 1999-08-30
FR2745290A1 (fr) 1997-08-29
EE9800265A (et) 1999-02-15
BR9707709B1 (pt) 2014-10-14
AR005999A1 (es) 1999-07-21
KR100486053B1 (ko) 2005-06-16
BG102691A (en) 1999-06-30
JP2000505469A (ja) 2000-05-09
DE69712610D1 (de) 2002-06-20
BG63207B1 (bg) 2001-06-29
ES2176698T3 (es) 2002-12-01
PT885234E (pt) 2002-10-31
PL328608A1 (en) 1999-02-01
JP4102440B2 (ja) 2008-06-18
UA58504C2 (uk) 2003-08-15
EP0885234B1 (de) 2002-05-15
CZ258798A3 (cs) 1998-12-16
CN1168734C (zh) 2004-09-29
IL125622A0 (en) 1999-04-11
HU227567B1 (en) 2011-08-29
HUP9902576A3 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
OA10845A (fr) Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments
EP0799833B1 (de) Erythromycin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2697524A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
EP0716093B1 (de) Erythromycin-Derivate, Verfahren zur Herstellung und Verwendung als Arzneimittel
EP1016669B1 (de) Erythromycin-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1004592B1 (de) Derivate von Erythromycin, ihr Verfahren zur Herstellung, und ihre Verwendung als Arzneimittel
EP0974598B1 (de) Neue Erythromycin-Derivate, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
CA2118564C (fr) Derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0931088B1 (de) Erythromycin-derivate, verfahren zur herstellung und verwendung als arzneimittel
CA2273985C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2754821A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP1000952B1 (de) Neue 2-Halogen-Derivate von 5-O-Desosaminylerythronolid A, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
FR2691464A1 (fr) Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
EP0946580B1 (de) Erythromycin-derivate, verfahren zu ihrer herstellung und ihrer verwendung
CA2338172C (fr) Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
CA2247175C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2792637A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2707088A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2780977A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2697523A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.